Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction Between Ticagrelor and Fentanyl in PCI (FACTPCI)
NCT03476369Phase 4Terminated
- Sponsor
- Guthrie
- Start
- Apr 2018
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Guthrie. Started Apr 2018; status: terminated.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03476369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476369.